First drug approved for most common inherited kidney disease

TRENTON, N.J. (AP) — The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most common inherited kidney disease. Jynarque (jihn-AR’-kew), from Japan’s Otsuka Pharmaceutical, was approved Tuesday for autosomal dominant polycystic kidney disease. The progressive genetic disorder is the fourth-leading cause of kidney failure. It […]